APLS

Apellis Pharmaceuticals (APLS)

Apellis Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:APLS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	23:00	GlobeNewswire Inc.	Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/22	05:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/14	21:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/14	21:00	GlobeNewswire Inc.	Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/10	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/09	06:13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/07	20:05	GlobeNewswire Inc.	Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/07	20:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/06	20:00	GlobeNewswire Inc.	Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/05/01	20:00	GlobeNewswire Inc.	Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/04/26	20:15	GlobeNewswire Inc.	Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/04/23	20:00	GlobeNewswire Inc.	Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/04/05	05:05	GlobeNewswire Inc.	Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/04/01	20:00	GlobeNewswire Inc.	Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/12	05:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/11	20:00	GlobeNewswire Inc.	Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/09	06:10	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/08	21:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/07	06:05	GlobeNewswire Inc.	Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/06	06:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/06	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/02	06:25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/02	03:37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/03/01	07:10	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/02/27	21:35	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/02/27	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/02/27	21:05	GlobeNewswire Inc.	Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/02/27	21:01	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/02/26	21:00	GlobeNewswire Inc.	Apellis Pharmaceuticals to Present at Upcoming Investor Conferences	NASDAQ:APLS	Apellis Pharmaceuticals Inc
2024/02/20	21:00	GlobeNewswire Inc.	Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:APLS	Apellis Pharmaceuticals Inc